Becton Dickinson Case

Question 1 How the medical industry changed (from 1983 before 1983 on). What is the impact on BD? How BD builds market share of 80% in this market. Competitors other than BD tried to join but they did not succeed. In 1983, the entire healthcare industry was influenced by changes in the way the US government paid back to Medicare patients at hospitals (40% of all hospital days). Let's see the situation before and after these changes.

The main problem with "Becton Dickinson and needle sticks" is the brand of syringes used by the hospital. These syringes caused a large number of patients, nurses and civilians who were infected with traumatic diseases such as hepatitis B, hepatitis C and AIDS. In 1990, it was emphasized as one of the people with the highest infection rate of syringes. In this case, Dickinson 's acupuncture is the cause of this health crisis, Dickinson' s acupuncture treatment is well known as the best selling acupuncture on the market, aiming at a reasonable price that hospitals do not want to buy I will.

Mr. Bill Kozy, president of Becton Dickinson, faced three major problems as it changed the company's performance in a cross-border manner. The structure of the world's blood collection business and its allocation of resources and assets is mainly the first issue of Bill Kozy. In this issue, complex discussions will be held among BD executives to decide where to develop R & D resources and functions. Since BD was established in the United States, there is a problem in transferring R & D to other countries. The second problem facing Bill Kozy is to combine "evolution of important decision making processes such as human resources and new global strategies, changes in the structures of global blood collection teams and global product development" . Some administrators want to control things with their own hands, but this makes it difficult to reach agreement on important tasks.